United States — Food and Drug Administration & Alzheimer s Association
4 shared events · Importance 3 · Last updated Aug 04, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
United States — Food and Drug Administration: Previously cleared a p-tau217 test for diagnostic use; regulatory stance influences adoption.
Alzheimer s Association: Venue for presenting the research; highlights conference's role in disseminating Alzheimer's research.
Jul 15, 2026 · 56 articles
Tech
United States — Food and Drug Administration: FDA approval would be required for diranersen to reach the market, following potential Phase III success.
Alzheimer s Association: The Alzheimer s Association hosted the conference where results were presented and commented on the significance of the findings.
Jul 14, 2026 · 22 articles
Tech
United States — Food and Drug Administration: The FDA granted Fast Track Designation to PMN310 in July 2025, facilitating development.
Alzheimer s Association: The Alzheimer s Association hosted AAIC 2026 where the data were presented, providing a key platform.
Jul 14, 2026 · 6 articles
Tech
United States — Food and Drug Administration: FDA granted Fast Track Designation to PMN310 in July 2025.
Alzheimer s Association: Dr. Weiner received awards from the Alzheimer s Association.
Jul 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Alzheimer s Association interact across events, view sentiment trends, and discover connected entities.
Open Dashboard